Mon 12 Feb | Providence Journal
The clinical trial seeks to assess the safety, tolerability and effectiveness of the experimental drug Tauriel in people with early to mild signs of Alzheimer’s, according to the hospital’s Memory and Aging Program. The Butler group is affiliated with The Warren Alpert Medical School of Brown University.